FAST Company



Melio is developing a rapid broad-based platform for microbial identification. Our patent pending technology enables detection, identification and quantification of all common microbes within a highly scalable framework. This low complexity and single cell sensitive test leverages machine learning to scale the technology across many contexts without the need for re-design of molecular methods. It has use in microbial profiling for infectious disease diagnostics, water and food testing, environmental monitoring, identifying pathogen outbreak and in research settings for profiling laboratory specimens and creating standards. Our goal is to deliver a user friendly, near point of care and low-cost platform with custom software for rapid profiling of samples across various industries. Currently, we are focused on timely identification of pathogens causing acute infections in newborns.